3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Leukemia, Hairy Cell
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Noonan syndrome 3
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Medulloblastoma
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Genomic Instability
1
Ependymoma
1
Colorectal Neoplasms
1
Central Nervous System Neoplasms
1
Interventions
Radiosurgery
25
Temozolomide
16
Magnetic Resonance Spectroscopy
14
pembrolizumab
11
Bevacizumab
11
Nivolumab
10
Ipilimumab
8
Specimen Handling
6
Memantine
6
abemaciclib
5
Radiotherapy
5
Mental Status and Dementia Tests
5
Blood Specimen Collection
5
Radiation
4
entrectinib
3
Surveys and Questionnaires
3
Sodium Chloride
3
Saline Solution
3
Receptors, Interleukin-8B
3
Proton Therapy
3
Lomustine
3
trastuzumab deruxtecan
2
trametinib
2
pertuzumab
2
osimertinib
2
lenvatinib
2
fluciclovine F-18
2
contrast agent BR1
2
atezolizumab
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Vemurafenib
×
90 days
×
Clear all
No trials found.